The correct application of nanotechnology for the treatment and control of antimicrobial resistance requires the implementation of translational science protocols capable of selecting the most active products with the lowest toxicity and that can be applied in the different areas where they may be needed. In this order of ideas, the selection of a reproducible antimicrobial platform that can be scalable, robust, and automatable becomes a necessity to be solved by nanotechnology researchers. Thus, the design and development of nanomaterials should be together with the implementation of evaluation and toxicity protocols in order to determine the promising nanoproducts to be used in the different innovations. For this reason, the objective of this chapter is to analyze the elements to be considered in the selection, implementation, and standardization of the necessary platforms to translate